EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression. - Dou, Dongwei; Ge, Xin; Wang, Xinxing; Xu, Xiaodong; Zhang, Zhe; Seng, Jingjing; Cao, Zhang; Gu, Yuanting; Han, Mingli (OncoTargets & Therapy, 2019)